-

Top Scholars from Home and Abroad Gather at CCHIO&AOS Oncology Event, Planning Cancer Prevention and Control and Integrated Diagnosis and Treatment with a Global Perspective!
Uniting China, Linking the World. From November 14-17, the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) and the 4th Asian Oncology Society (AOS) were held concurrently in Xi’an, bringing an academic feast to the Chinese medical community and providing an opportunity for in-depth exchange and cooperation in the global oncology field. The conference covered…
-

National Healthy Lifestyle Promotion Month | Focusing on Breast Health: Authoritative Experts Discuss Breast Cancer Prevention and Treatment — Part I
Healthy living for all, together we uphold, and start a new chapter! September is the National Healthy Lifestyle Promotion Month. We focus on breast cancer, a significant disease threatening women’s health, and have specially invited authoritative experts in the field of breast cancer from China to discuss the scientific prevention and treatment of breast cancer…
-

Professor Yehui Shi: The Epigenetic Regulation of HR+ Metastatic Breast Cancer—A Review of the Development Path of HDACi Entinostat
Histone deacetylases (HDACs) are overexpressed in various tumors and are closely related to tumor progression and drug resistance. In hormone receptor-positive (HR+) breast cancer, HDAC overexpression leads to resistance to endocrine therapy and CDK4/6 inhibitors. The targeted application of HDAC inhibitors (HDACi) can effectively block this process, bringing better prognosis to patients. Entinostat, introduced in…
-

World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (2)
Breast cancer is one of the most common malignant tumors in women and is often referred to as the “pink killer,” posing a serious threat to women’s health. The World Health Organization has designated October as “World Breast Cancer Awareness Month” (also known as Pink Ribbon Month) to raise women’s awareness of breast cancer prevention.…
-

World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (1)
Breast cancer is one of the most common malignant tumors in women and is often referred to as the “pink killer,” posing a serious threat to women’s health. The World Health Organization has designated October as “World Breast Cancer Awareness Month” (also known as Pink Ribbon Month) to raise women’s awareness of breast cancer prevention.…
-

Global Trends in HBV-Related Liver Cancer: A Growing Concern
Published on February 11, 2025, in Hepatology, this study sheds light on the persistent global burden of hepatitis B virus (HBV)-related liver cancer. While significant progress has been made in…
-

SABCS 2024 | Prof. Charles Geyer: NSABP B-59—Atezolizumab in Neoadjuvant Triple-Negative Breast Cancer
Oncology Frontier: Please share the key findings of the NSABP B-59/GBG-96-GeparDouze study. In particular, what are the highlights regarding the efficacy and safety of atezolizumab when added to neoadjuvant chemotherapy…
-

SABCS 2024 | Professor Janice Tsang: Looking Back at 2024, Sharing Highlight Studies and Insights in Early-Stage Breast Cancer
Oncology Frontier:You introduced “Early Breast Cancer Updates” in Year in Review session. Please review the lecture and tell us about the research progress in the field of early breast cancer…